India Ministries Consider Mylan Takeover Of Agila With Strings Attached
This article was originally published in PharmAsia News
Executive Summary
Several India ministries are weighing in on the Mylan Laboratories proposal to buy Agila Specialties, the injectables unit of Strides Arcolabs for $1.6 billion, including making approval unusually conditional.